Trans-Hit Bio

Laval, Canada Founded: 2009 • Age: 17 yrs Acquired By Brooks Automation
Tissue examination services are offered by this CRO in Canada.

About Trans-Hit Bio

Trans-Hit Bio is a Healthcare company based in Laval (Canada) founded in 2009 by Pascal Puchois, and was acquired by Brooks Automation in December 2020. Tissue examination services are offered by this CRO in Canada. Its chief executive, as recorded, is Pascal Puchois. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Pathology & Imaging.

Company details

Trans-Hit Bio was established in 2009 in Laval, Canada, as a contract research organization (CRO) in the biotechnology sector. Tissue examination services are provided to support pharmaceutical and research needs. Operations are centered on histological analysis and related expertise. The company is led by founder and CEO Pascal Puchois, with its online presence maintained at trans-hit.com.

  • Headquarters Laval, Canada
  • Founders Pascal Puchois
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website trans-hit.com
  • Social LinkedIn X
  • Acquired by Brooks Automation (Dec 2020)
Key Metrics

Investors in Trans-Hit Bio

Trans-Hit Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Brooks Automation.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Vacuum robots for semiconductor wafer handling are developed.
1978brooks.comChelmsford, United States
Premium access

Investor details for Trans-Hit Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Trans-Hit Bio

1 people are tracked at Trans-Hit Bio (1 in leadership).

NameRoleGroup
Pascal Puchois
Founder & CEOLeadership
Premium access

Complete people profiles for Trans-Hit Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Trans-Hit Bio

2 dated milestones of Trans-Hit Bio across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Trans-Hit Bio is founded.
  2. Exit Acquired by Brooks Automation.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Trans-Hit Bio

Premium access

Complete news archive for Trans-Hit Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trans-Hit Bio

Trans-Hit Bio was founded in 2009.

Trans-Hit Bio is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.

Pascal Puchois is the CEO of Trans-Hit Bio, as recorded in our data. They have also founded this company.

Trans-Hit Bio was established in 2009 in Laval, Canada, as a contract research organization (CRO) in the biotechnology sector. Tissue examination services are provided to support pharmaceutical and research needs. Operations are centered on histological analysis and related expertise. The company is led by founder and CEO Pascal Puchois, with its online presence maintained at trans-hit.com.

Trans-Hit Bio has 1 investor. Key investors include Brooks Automation.

Yes. Trans-Hit Bio was acquired by Brooks Automation in December 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available